Skip to main content


Figure 6 | EJNMMI Research

Figure 6

From: Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT

Figure 6

18 F-FDG PET and immuno-PET. Patient with follicular lymphoma injected with 111In- and 90Y-Zevalin® (Bayer) 7 days apart. (A) Pre-therapeutic scan after injection with 18 F-FDG and (B) immunoscintigraphy recorded 6 days (bottom left) after 111In-Zevalin® (Bayer) injection showed an abnormal focus corresponding to a lymphoma mass detected on the pre-RAIT CT and 18 F-FDG PET (A). No relevant signal was detected by 90Y-PET (bottom right).

Back to article page